[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Inflammatory Bowel Disease Market Report 2018

February 2018 | 106 pages | ID: A7A5512A8CBQEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Inflammatory Bowel Disease market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Inflammatory Bowel Disease for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Inflammatory Bowel Disease market competition by top manufacturers/players, with Inflammatory Bowel Disease sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
  • Abbvie
  • Merck
  • Abbott Laboratories
  • Biogen Idec
  • Janssen Pharmaceuticals
  • Merck & Company
  • Mitsubishi Tanabe
  • Salix Pharmaceuticals
  • Genentech
  • Shire
  • UCB
  • Akebia Therapeutics
  • Amgen
  • ChemoCentryx
  • Novartis
  • Boehringer Ingelheim
  • Celltrion
  • Novo Nordisk
  • Ferring Pharmaceuticals
  • Galapagos
  • ...
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • 5-ASA
  • Antibiotics
  • Immunomodulators
  • Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Clinic
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Inflammatory Bowel Disease Market Report 2018

1 INFLAMMATORY BOWEL DISEASE OVERVIEW

1.1 Product Overview and Scope of Inflammatory Bowel Disease
1.2 Classification of Inflammatory Bowel Disease by Product Category
  1.2.1 Asia-Pacific Inflammatory Bowel Disease Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Inflammatory Bowel Disease Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 5-ASA
  1.2.4 Antibiotics
  1.2.5 Immunomodulators
  1.2.6 Other
1.3 Asia-Pacific Inflammatory Bowel Disease Market by Application/End Users
  1.3.1 Asia-Pacific Inflammatory Bowel Disease Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 Asia-Pacific Inflammatory Bowel Disease Market by Region
  1.4.1 Asia-Pacific Inflammatory Bowel Disease Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Inflammatory Bowel Disease (2013-2025)
  1.5.1 Asia-Pacific Inflammatory Bowel Disease Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Inflammatory Bowel Disease Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC INFLAMMATORY BOWEL DISEASE COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Inflammatory Bowel Disease Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Inflammatory Bowel Disease Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Inflammatory Bowel Disease Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Inflammatory Bowel Disease (Volume and Value) by Type
  2.2.1 Asia-Pacific Inflammatory Bowel Disease Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Inflammatory Bowel Disease Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Inflammatory Bowel Disease (Volume) by Application
2.4 Asia-Pacific Inflammatory Bowel Disease (Volume and Value) by Region
  2.4.1 Asia-Pacific Inflammatory Bowel Disease Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Inflammatory Bowel Disease Revenue and Market Share by Region (2013-2018)

3 CHINA INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

3.1 China Inflammatory Bowel Disease Sales and Value (2013-2018)
  3.1.1 China Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  3.1.3 China Inflammatory Bowel Disease Sales Price Trend (2013-2018)
3.2 China Inflammatory Bowel Disease Sales Volume and Market Share by Type
3.3 China Inflammatory Bowel Disease Sales Volume and Market Share by Application

4 JAPAN INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Inflammatory Bowel Disease Sales and Value (2013-2018)
  4.1.1 Japan Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Inflammatory Bowel Disease Sales Price Trend (2013-2018)
4.2 Japan Inflammatory Bowel Disease Sales Volume and Market Share by Type
4.3 Japan Inflammatory Bowel Disease Sales Volume and Market Share by Application

5 SOUTH KOREA INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Inflammatory Bowel Disease Sales and Value (2013-2018)
  5.1.1 South Korea Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Inflammatory Bowel Disease Sales Price Trend (2013-2018)
5.2 South Korea Inflammatory Bowel Disease Sales Volume and Market Share by Type
5.3 South Korea Inflammatory Bowel Disease Sales Volume and Market Share by Application

6 TAIWAN INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Inflammatory Bowel Disease Sales and Value (2013-2018)
  6.1.1 Taiwan Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Inflammatory Bowel Disease Sales Price Trend (2013-2018)
6.2 Taiwan Inflammatory Bowel Disease Sales Volume and Market Share by Type
6.3 Taiwan Inflammatory Bowel Disease Sales Volume and Market Share by Application

7 INDIA INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

7.1 India Inflammatory Bowel Disease Sales and Value (2013-2018)
  7.1.1 India Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  7.1.3 India Inflammatory Bowel Disease Sales Price Trend (2013-2018)
7.2 India Inflammatory Bowel Disease Sales Volume and Market Share by Type
7.3 India Inflammatory Bowel Disease Sales Volume and Market Share by Application

8 SOUTHEAST ASIA INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Inflammatory Bowel Disease Sales and Value (2013-2018)
  8.1.1 Southeast Asia Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Inflammatory Bowel Disease Sales Price Trend (2013-2018)
8.2 Southeast Asia Inflammatory Bowel Disease Sales Volume and Market Share by Type
8.3 Southeast Asia Inflammatory Bowel Disease Sales Volume and Market Share by Application

9 AUSTRALIA INFLAMMATORY BOWEL DISEASE (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Inflammatory Bowel Disease Sales and Value (2013-2018)
  9.1.1 Australia Inflammatory Bowel Disease Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Inflammatory Bowel Disease Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Inflammatory Bowel Disease Sales Price Trend (2013-2018)
9.2 Australia Inflammatory Bowel Disease Sales Volume and Market Share by Type
9.3 Australia Inflammatory Bowel Disease Sales Volume and Market Share by Application

10 ASIA-PACIFIC INFLAMMATORY BOWEL DISEASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Pfizer Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Abbvie
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Abbvie Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Merck
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Merck Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Abbott Laboratories
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Abbott Laboratories Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Biogen Idec
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Biogen Idec Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Janssen Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Janssen Pharmaceuticals Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Merck & Company
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Merck & Company Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Mitsubishi Tanabe
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Mitsubishi Tanabe Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Salix Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Salix Pharmaceuticals Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Genentech
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Inflammatory Bowel Disease Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Genentech Inflammatory Bowel Disease Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Shire
10.12 UCB
10.13 Akebia Therapeutics
10.14 Amgen
10.15 ChemoCentryx
10.16 Novartis
10.17 Boehringer Ingelheim
10.18 Celltrion
10.19 Novo Nordisk
10.20 Ferring Pharmaceuticals
10.21 Galapagos

11 INFLAMMATORY BOWEL DISEASE MANUFACTURING COST ANALYSIS

11.1 Inflammatory Bowel Disease Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Inflammatory Bowel Disease

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Inflammatory Bowel Disease Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Inflammatory Bowel Disease Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC INFLAMMATORY BOWEL DISEASE MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Inflammatory Bowel Disease Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Inflammatory Bowel Disease Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Inflammatory Bowel Disease Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Inflammatory Bowel Disease Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Inflammatory Bowel Disease Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Inflammatory Bowel Disease Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Inflammatory Bowel Disease Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Inflammatory Bowel Disease Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Inflammatory Bowel Disease Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Inflammatory Bowel Disease Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Inflammatory Bowel Disease Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Inflammatory Bowel Disease Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Inflammatory Bowel Disease Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Inflammatory Bowel Disease
Figure Asia-Pacific Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Volume Market Share by Type (Product Category) in 2017
Figure 5-ASA Product Picture
Figure Antibiotics Product Picture
Figure Immunomodulators Product Picture
Figure Other Product Picture
Figure Asia-Pacific Inflammatory Bowel Disease Sales (MT) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Inflammatory Bowel Disease by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Inflammatory Bowel Disease Market Size (Million USD) by Region (2013-2025)
Figure China Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Volume (MT) and Growth Rate (2013-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Market Major Players Product Sales Volume (MT)(2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Sales (MT) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Inflammatory Bowel Disease Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Inflammatory Bowel Disease Sales Share by Players/Suppliers
Figure Asia-Pacific Inflammatory Bowel Disease Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Inflammatory Bowel Disease Revenue Share by Players
Figure 2017 Asia-Pacific Inflammatory Bowel Disease Revenue Share by Players
Table Asia-Pacific Inflammatory Bowel Disease Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Sales Share by Type (2013-2018)
Figure Sales Market Share of Inflammatory Bowel Disease by Type (2013-2018)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease by Type (2013-2018)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Sales Volume (MT) and Market Share by Region (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Sales Share by Region (2013-2018)
Figure Sales Market Share of Inflammatory Bowel Disease by Region (2013-2018)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Market Share by Region in 2017
Table Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Inflammatory Bowel Disease by Region (2013-2018)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue Market Share by Region in 2017
Table Asia-Pacific Inflammatory Bowel Disease Sales Volume (MT) and Market Share by Application (2013-2018)
Table Asia-Pacific Inflammatory Bowel Disease Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Market Share by Application (2013-2018)
Figure China Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure China Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table China Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table China Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure China Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table China Inflammatory Bowel Disease Sales Volume (MT) by Applications (2013-2018)
Table China Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure China Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Figure Japan Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Japan Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table Japan Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table Japan Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure Japan Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table Japan Inflammatory Bowel Disease Sales Volume (MT) by Applications (2013-2018)
Table Japan Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure Japan Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Figure South Korea Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure South Korea Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table South Korea Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table South Korea Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure South Korea Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table South Korea Inflammatory Bowel Disease Sales Volume (MT) by Applications (2013-2018)
Table South Korea Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure South Korea Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Figure Taiwan Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Taiwan Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table Taiwan Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table Taiwan Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table Taiwan Inflammatory Bowel Disease Sales Volume (MT) by Applications (2013-2018)
Table Taiwan Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Figure India Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure India Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table India Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table India Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure India Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table India Inflammatory Bowel Disease Sales Volume (MT) by Application (2013-2018)
Table India Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure India Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Figure Southeast Asia Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Southeast Asia Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table Southeast Asia Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table Southeast Asia Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table Southeast Asia Inflammatory Bowel Disease Sales Volume (MT) by Applications (2013-2018)
Table Southeast Asia Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Figure Australia Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Australia Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Inflammatory Bowel Disease Sales Price (USD/Kg) Trend (2013-2018)
Table Australia Inflammatory Bowel Disease Sales Volume (MT) by Type (2013-2018)
Table Australia Inflammatory Bowel Disease Sales Volume Market Share by Type (2013-2018)
Figure Australia Inflammatory Bowel Disease Sales Volume Market Share by Type in 2017
Table Australia Inflammatory Bowel Disease Sales Volume (MT) by Applications (2013-2018)
Table Australia Inflammatory Bowel Disease Sales Volume Market Share by Application (2013-2018)
Figure Australia Inflammatory Bowel Disease Sales Volume Market Share by Application in 2017
Table Pfizer Inflammatory Bowel Disease Basic Information List
Table Pfizer Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Pfizer Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Abbvie Inflammatory Bowel Disease Basic Information List
Table Abbvie Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Abbvie Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Merck Inflammatory Bowel Disease Basic Information List
Table Merck Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Merck Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Merck Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Abbott Laboratories Inflammatory Bowel Disease Basic Information List
Table Abbott Laboratories Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Abbott Laboratories Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Biogen Idec Inflammatory Bowel Disease Basic Information List
Table Biogen Idec Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Biogen Idec Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Basic Information List
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Janssen Pharmaceuticals Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Merck & Company Inflammatory Bowel Disease Basic Information List
Table Merck & Company Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Merck & Company Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Mitsubishi Tanabe Inflammatory Bowel Disease Basic Information List
Table Mitsubishi Tanabe Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Mitsubishi Tanabe Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Salix Pharmaceuticals Inflammatory Bowel Disease Basic Information List
Table Salix Pharmaceuticals Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Salix Pharmaceuticals Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Genentech Inflammatory Bowel Disease Basic Information List
Table Genentech Inflammatory Bowel Disease Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2013-2018)
Figure Genentech Inflammatory Bowel Disease Sales (MT) and Growth Rate (2013-2018)
Figure Genentech Inflammatory Bowel Disease Sales Market Share in Asia-Pacific (2013-2018)
Figure Genentech Inflammatory Bowel Disease Revenue Market Share in Asia-Pacific (2013-2018)
Table Shire Inflammatory Bowel Disease Basic Information List
Table UCB Inflammatory Bowel Disease Basic Information List
Table Akebia Therapeutics Inflammatory Bowel Disease Basic Information List
Table Amgen Inflammatory Bowel Disease Basic Information List
Table ChemoCentryx Inflammatory Bowel Disease Basic Information List
Table Novartis Inflammatory Bowel Disease Basic Information List
Table Boehringer Ingelheim Inflammatory Bowel Disease Basic Information List
Table Celltrion Inflammatory Bowel Disease Basic Information List
Table Novo Nordisk Inflammatory Bowel Disease Basic Information List
Table Ferring Pharmaceuticals Inflammatory Bowel Disease Basic Information List
Table Galapagos Inflammatory Bowel Disease Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inflammatory Bowel Disease
Figure Manufacturing Process Analysis of Inflammatory Bowel Disease
Figure Inflammatory Bowel Disease Industrial Chain Analysis
Table Raw Materials Sources of Inflammatory Bowel Disease Major Manufacturers in 2017
Table Major Buyers of Inflammatory Bowel Disease
Table Distributors/Traders List
Figure Asia-Pacific Inflammatory Bowel Disease Sales Volume (MT) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Price (USD/Kg) and Trend Forecast (2018-2025)
Table Asia-Pacific Inflammatory Bowel Disease Sales Volume (MT) Forecast by Region (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue Market Share Forecast by Region in 2025
Figure China Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure China Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Japan Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure South Korea Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Taiwan Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure India Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Inflammatory Bowel Disease Sales (MT) and Growth Rate Forecast (2018-2025)
Figure Australia Inflammatory Bowel Disease Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Inflammatory Bowel Disease Sales (MT) Forecast by Type (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Inflammatory Bowel Disease Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Inflammatory Bowel Disease Price (USD/Kg) Forecast by Type (2018-2025)
Table Asia-Pacific Inflammatory Bowel Disease Sales (MT) Forecast by Application (2018-2025)
Figure Asia-Pacific Inflammatory Bowel Disease Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories